Source: Cambridge Network

Ablatus: eg technology partners with Ablatus following 1m Innovate UK grant

eg technology is pleased to continue its ongoing partnership with Cambridge-based Ablatus Therapeutics, to help develop its novel minimally invasive treatment for soft tissue tumours. eg technology is pleased to continue its ongoing partnership with Cambridge-based Ablatus Therapeutics, to help develop its novel minimally invasive treatment for soft tissue tumours.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Chung Looi's photo - CEO of Ablatus

CEO

Chung Looi

CEO Approval Rating

82/100

Read more